We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pediatric Asthma Controller Trial (PACT)

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00272506
First Posted: January 6, 2006
Last Update Posted: July 12, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Childhood Asthma Research and Education Network
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
  Purpose
To evaluate current and novel therapies and management strategies for children with asthma. The emphasis is on clinical trials that help identify optimal therapy for children with different asthma phenotypes, genotypes, and ethnic backgrounds and children at different developmental stages.

Condition Intervention Phase
Asthma Lung Diseases Drug: inhaled corticosteroid Drug: long-acting beta2-agonist Phase 3

Study Type: Interventional
Study Design: Intervention Model: Crossover Assignment
Primary Purpose: Treatment

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: August 2002
Study Completion Date: September 2004
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   up to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria
Asthmatic children from birth to 18 years. Emphasis is placed on infants and young children through 5 years of age.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00272506


Sponsors and Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Childhood Asthma Research and Education Network
Investigators
OverallOfficial: Vernon Chinchilli Milton S. Hershey Medical Center
OverallOfficial: Robert Lemanske University of Wisconsin, Madison
OverallOfficial: Fernando Martinez University of Arizona
OverallOfficial: Robert Strunk Washington University School of Medicine
OverallOfficial: Stanley Szefler National Jewish Health
OverallOfficial: Robert Zeiger University of California, San Diego
  More Information

ClinicalTrials.gov Identifier: NCT00272506     History of Changes
Other Study ID Numbers: 351
First Submitted: January 3, 2006
First Posted: January 6, 2006
Last Update Posted: July 12, 2016
Last Verified: January 2006

Additional relevant MeSH terms:
Asthma
Lung Diseases
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases